Antengene
Help people with cancer
live longer and better.
About us

About Us

Management Team


John Z. Gong,M.D.,Ph.D.

John Z. Gong,M.D.,Ph.D.

Chairman and CEO

— US FDA Reviewer for 10 years, conducted primary and critical reviews of numerous IND and NDA applications for both small molecules and biologics
— VP of Drug Development and Regulatory Affairs of BeiGene
— With more than 30 years of global industry and academic experience, Dr. John Gong devoted into new drug R&D in different stakeholders from FDA, CRO to biotech companies. He gained rich experience on following field: leading global new drug development, manufacture and commercialization, the process of identifying, license-in and co-development drug candidates, strategic planning for global development, registration and commercialization, pre-clinical and clinical trial designs, GLP/GCP/GMP regulations, project risk management
—  Ph.D. degree in Toxicology from New York University in 1996 and medical degree from Beijing Medical College in 1984

—  Member of editorial board of Chinese Journal of New Drugs, Progress in Pharmaceutical Sciences and DIA advisory committee, International Innovative Drug Supervision Professional Committee member of the PhIRDA

  • Jing Zhang

    Jing Zhang / USCPA

    Chief Financial Officer

    Bachelor’s degree in medical nutrition from Yat-sen University of Medical Sciences; Master in Accountancy, University of South Carolina

    — Member of AICPA, worked for United Technologies and Anthem, 20+ years as global healthcare financial management executive in US MNC, health insurance company and big 4 audit firms

  • Fang Xia

    Fang Xia

    Secretary to the Board, Head of Public Relations

    — Master in Pharmacognosy,Peking University Health Science Center,MBA in Harvard Business School.

    — Worked as deputy director of product design center in Taiji Group in Beijing, responsible for product registration and regulatory communication.

  • Ming Zhu

    Ming Zhu

    Vice President, Head of Company Operations

    — Bachelor in Finance, Suzhou University

    — Previous experience in WuXi AppTec, JOINN Laboratories and BL Pharma, over 15 years' operation management experience

  • Yue He

    Yue He

    Executive Director, Quality Management

    — Master in Clinical Medicine in Sichuan University, MBA in Hong Kong Asia Business College

    — Worked for BeiGene,  Ronggang Biotechnology Pharma and Baitai Biopharmaceutical, 13 years of experience in the pharmaceutical industry

  • Jian Zhou, Ph.D.

    Jian Zhou, Ph.D.

    Vice President, Small Molecule CMC

    — Master in Medicinal Chemistry, Peking University; Ph.D. in Bioorganic Chemistry, University College Dublin, Ireland; Post-doc, National University of Ireland-Galway, Ireland

    — Comprehensive experience in drug R&D, manufacturing, quality research and the construction of pharmaceutical plants

  • Qiang Feng, Ph.D.

    Qiang Feng, Ph.D.

    Senior Director, Biopharmaceutical CMC

    — Bachelor of Pharmacy, Xi'an Jiaotong University, Master and Ph.D. in Cell Biology, Fourth Military Medical University

    — Worked for the Fourth Military Medical University, Jiangsu Pacific Minox, CANbridge, Henlius and other universities and pharmaceutical enterprises, and his working experience covers different stages of drug R&D and production. Published a number of SCI papers, obtained a number of patents, and undertaken or participated in a number of national key scientific research projects

  • Jing Zhang

    Jing Zhang / USCPA

    Chief Financial Officer

    — Bachelor’s degree in medical nutrition from Yat-sen University of Medical Sciences; Master in Accountancy, University of South Carolina

    — Member of AICPA, worked for United Technologies and Anthem, 20+ years as global healthcare financial management executive in US MNC, health insurance company and big 4 audit firms

  • Fang Xia

    Fang Xia

    Secretary to the Board, Head of Public Relations

    — Master in Pharmacognosy,Peking University Health Science Center,MBA in Harvard Business School.

    — Worked as deputy director of product design center in Taiji Group in Beijing, responsible for product registration and regulatory communication

     

  • Ming Zhu

    Ming Zhu

    Vice President, Head of Company Operations

    — Bachelor in Finance, Suzhou University

    — Previous experience in WuXi AppTec, JOINN Laboratories and BL Pharma, over 15 years' operation management experience

     

  • Yue He

    Yue He

    Senior Director of the Quality Management

    — Master in Clinical Medicine in Sichuan University, MBA in Hong Kong Asia Business College

    — Worked for BeiGene,  Ronggang Biotechnology Pharma and Baitai Biopharmaceutical, 13 years of experience in the pharmaceutical industry

  • Jian Zhou, Ph.D.

    Jian Zhou, Ph.D.

    Vice President, Small Molecule CMC

    — Master in Medicinal Chemistry, Peking University; Ph.D. in Bioorganic Chemistry, University College Dublin, Ireland; Post-doc, National University of Ireland-Galway, Ireland

    — Comprehensive experience in drug R&D, manufacturing, quality research and the construction of pharmaceutical plants

  • Qiang Feng, Ph.D.

    Qiang Feng, Ph.D.

    Senior Director, Biopharmaceutical CMC

    — Bachelor of Pharmacy, Xi'an Jiaotong University, Master and Ph.D in Cell Biology, Fourth Military Medical University

    — Worked for the Fourth Military Medical University, Jiangsu Pacific Minox, CANbridge, Henlius and other universities and pharmaceutical enterprises, and his working experience covers different stages of drug R&D and production. Published a number of SCI papers, obtained a number of patents, and undertaken or participated in a number of national key scientific research projects.